Associated Banc Corp Reata Pharmaceuticals Inc Transaction History

Associated Banc Corp

  • $3.37 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

May 05, 2021
SELL
$94.25 - $132.81 $942 - $1,328
-10 Closed
0 $0
Q3 2020

Nov 12, 2020
BUY
$93.53 - $163.34 $935 - $1,633
10 New
10 $1,000
Q2 2020

Aug 14, 2020
SELL
$126.3 - $176.56 $1,010 - $1,412
-8 Closed
0 $0
Q1 2020

May 14, 2020
BUY
$124.16 - $247.74 $993 - $1,981
8 New
8 $1,000

Others Institutions Holding RETA

# of Institutions
5
Shares Held
62.7K
Call Options Held
0
Put Options Held
0
View Full List

About REATA PHARMACEUTICALS INC

RETA Quotes by TradingView
  • Ticker RETA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 31,583,200
  • Description
  • Reata Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, identifies, develops, and commercializes novel therapeutics for patients with serious or life-threatening diseases. The company is developing Phase 3 clinical trial programs, including bardoxolone methyl (bardoxolone) for the treatment of patients with chronic kidney diseas...
More about RETA
Track This Portfolio

Track Associated Banc Corp Portfolio

Follow Associated Banc Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Associated Banc Corp, based on Form 13F filings with the SEC.

News

Stay updated on Associated Banc Corp with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email